Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.760
-0.040 (-2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.
It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system.
In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs.
Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Nautilus Biotechnology, Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 167 |
| CEO | Sujal Patel |
Contact Details
Address: 2701 Eastlake Avenue East Seattle, Washington 98102 United States | |
| Phone | 206 333 2001 |
| Website | nautilus.bio |
Stock Details
| Ticker Symbol | NAUT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001808805 |
| CUSIP Number | 63909J108 |
| ISIN Number | US63909J1088 |
| Employer ID | 98-1541723 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Sujal M. Patel | Co-Founder, Chief Executive Officer, President, Secretary and Director |
| Dr. Parag Mallick Ph.D. | Co-Founder, Chief Scientist and Director |
| Anna Mowry | Chief Financial Officer and Treasurer |
| Matthew B. Murphy ESQ. | General Counsel |
| Chris Blessington | Vice President of Corporate Marketing and Communications |
| Kentaro Suzuki | Chief Marketing Officer |
| Gwen E. Weld | Chief People Officer |
| Nick A. Nelson | Chief Business Officer and Senior Vice President of Business Development |
| Dr. Subra Sankar Ph.D. | Senior Vice President of Product Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 17, 2024 | 144 | Filing |
| Dec 9, 2024 | 144 | Filing |
| Dec 3, 2024 | 144 | Filing |
| Nov 26, 2024 | 144 | Filing |
| Nov 21, 2024 | 144 | Filing |
| Nov 19, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Nov 12, 2024 | 144 | Filing |
| Nov 8, 2024 | 144 | Filing |
| Nov 7, 2024 | 144 | Filing |